Beta Bionics, Inc. Common Stock

BBNXNASDAQ • USD
ThemeMedical Devices & HealthTech›Wearable Medical Devices
15.91 USD
↗ 1.18 (8.01%)AT CLOSE (11:59 AM EDT)
15.94
↗ 0.03 (0.19%)
POST MARKET (AS OF 05:46 PM EDT)
Post Market
AS OF 05:46 PM EDT
15.94
↗ 0.03 (0.19%)
🟢Market: OPEN

Beta Bionics, Inc. Common Stock (BBNX) trades at $15.94 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, BBNX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 25, 2026.

Open?$14.71
High?$16.63
Low?$14.62
Prev. Close?$14.73
Volume?1.1M
Avg. Volume?928.6K
VWAP?$15.94
Rel. Volume?1.18x
Bid / Ask
Bid?$13.26 × 100
Ask?$18.96 × 100
Spread?$5.70
Midpoint?$16.11
Valuation & Ratios
Market Cap?656.4M
Shares Out?44.6M
Float?37.7M
Float %?84.8%
P/E Ratio?N/A
P/B Ratio?2.42
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Themes
Medical Devices & HealthTech›Wearable Medical DevicesDigital Health & Telemedicine›Remote Patient Monitoring
Employees
423
Market Cap
656.4M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.betabionics.com
Listed
2025-01-30
Address
11 HUGHES
IRVINE, CA 92618
Phone: 949-427-7785
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
98
Short Sent.?
59
Piotroski F-Score?0/9Weak
Altman Z-Score?10.48Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.81%High
Short Interest?5.2M
Days to Cover?7.2
Free Float37.7M
Avg Daily Volume721.1K
Settlement Date2026-05-29
Financial Health
Current Ratio?10.69Strong
Quick Ratio?9.67Strong
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
66
2.42CHEAP▾
P/S?
Peers
100
S&P
22
5.95FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.3CHEAP▾
EV/Sales?
Peers
100
S&P
30
5.68FAIR▾
Returns & Efficiency
ROE?
S&P
7
-24.5%WEAK▾
ROA?
S&P
3
-21.8%WEAK▾
Cash Flow & Enterprise
FCF?$-61123000
Enterprise Value?$626.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist